Does pravastatin cause hair loss? This is a question raised by some patients taking this commonly prescribed cholesterol-lowering statin. Pravastatin belongs to the HMG-CoA reductase inhibitor class and is used to reduce LDL cholesterol and lower the risk of heart attack and stroke. According to its UK Summary of Product Characteristics, alopecia is classified as a rare adverse effect, potentially affecting up to 1 in 1,000 people. However, large clinical trials have not consistently confirmed a direct causal link. This article examines the available evidence, explores possible biological mechanisms, and explains what to do if you notice hair loss while taking pravastatin.
Summary: Pravastatin lists alopecia as a rare adverse effect (up to 1 in 1,000 people) in its UK Summary of Product Characteristics, but large clinical trials have not consistently confirmed a direct causal link.
- Alopecia is classified as a rare adverse effect of pravastatin, meaning it may affect up to 1 in 1,000 patients according to the UK SmPC.
- Pravastatin inhibits the mevalonate pathway, which theoretically could disrupt hair follicle cycling, but this mechanism has not been confirmed in controlled clinical studies.
- Hair loss is common in the general population, particularly in middle-aged and older adults — the same group most likely to be prescribed statins — making causality difficult to establish.
- Many other conditions and medicines (including anticoagulants, antithyroid drugs, and beta-blockers) can cause hair loss and must be excluded before attributing it to pravastatin.
- Patients should not stop pravastatin without medical advice, as its cardiovascular benefits are well established; a GP can investigate and consider switching to an alternative statin if needed.
- Suspected side effects from pravastatin, including hair loss, can be reported to the MHRA via the Yellow Card scheme at yellowcard.mhra.gov.uk.
Table of Contents
Am I eligible for weight loss injections?
Find out whether you might be eligible!
Answer a few quick questions to see whether you may be suitable for prescription weight loss injections (like Wegovy® or Mounjaro®).
- No commitment — just a quick suitability check
- Takes about 1 minute to complete
Pravastatin and Hair Loss: What the Evidence Shows
Alopecia is listed as a rare adverse effect of pravastatin in its UK SmPC, but large randomised controlled trials have not consistently confirmed a direct causal link, and most reports come from post-marketing surveillance.
Experiencing these side effects? Our pharmacists can help you navigate them →
It is important to place this in context. According to the UK Summary of Product Characteristics (SmPC) for pravastatin sodium, alopecia is classified as a rare adverse effect, meaning it may affect up to 1 in 1,000 people. The Medicines and Healthcare products Regulatory Agency (MHRA) and the European Medicines Agency (EMA) have received spontaneous reports of alopecia associated with statin use, but a definitive causal relationship has not been firmly established for pravastatin specifically.
Available clinical trial data do not consistently identify hair loss as a significant adverse effect of pravastatin compared with placebo. Most reports arise from post-marketing surveillance and individual case studies rather than large randomised controlled trials. While a link cannot be entirely ruled out, there is no robust clinical evidence confirming that pravastatin directly causes hair loss in the majority of patients. Anyone concerned about this side effect should discuss it with their GP or pharmacist rather than stopping the medication without medical advice, as the cardiovascular benefits of statins are well established.
| Side Effect | Frequency | Severity | Management |
|---|---|---|---|
| Alopecia (hair loss) | Rare — up to 1 in 1,000 patients (UK SmPC) | Mild; typically diffuse telogen effluvium pattern | Do not stop pravastatin; consult GP to review timeline and exclude other causes |
| Gastrointestinal disturbances (nausea, diarrhoea, constipation) | More common than alopecia; consult SmPC/BNF for precise frequency | Mild to moderate | Take with food; discuss with GP or pharmacist if persistent |
| Headache | Consult SmPC/BNF for precise frequency | Mild | Standard analgesia; inform GP if severe or persistent |
| Myalgia (muscle pain or weakness) | Consult SmPC/BNF for precise frequency | Mild to serious (rarely rhabdomyolysis) | Report to GP promptly; CK levels may be checked; do not stop without advice |
| Raised liver enzymes | Consult SmPC/BNF for precise frequency | Usually mild and transient; rarely clinically significant | Liver function monitored as clinically indicated; inform GP of symptoms |
| Suspected adverse effect (any) | N/A | N/A | Report via MHRA Yellow Card scheme (yellowcard.mhra.gov.uk) |
How Statins May Affect Hair Growth
Statins inhibit the mevalonate pathway, which theoretically could disrupt hair follicle cycling and trigger telogen effluvium, but this mechanism has not been confirmed in controlled clinical studies.
The following explanation is theoretical and has not been confirmed in controlled clinical studies; it is intended to help patients understand why a biological mechanism has been proposed, not to suggest that hair loss is a predictable or common consequence of taking pravastatin.
Not sure if this is normal? Chat with one of our pharmacists →
Hair follicles are metabolically active structures that depend on a range of biochemical processes, including cholesterol synthesis. Statins work by inhibiting HMG-CoA reductase, an enzyme involved in an early step of the mevalonate pathway — the same pathway that produces cholesterol. This pathway also generates other molecules, including coenzyme Q10 and certain isoprenoids, which play roles in cell signalling and energy metabolism.
Some researchers have proposed that by broadly suppressing the mevalonate pathway, statins could theoretically interfere with the normal cycling of hair follicles. Hair growth occurs in phases — anagen (growth), catagen (transition), and telogen (resting and shedding) — and disruption to cellular signalling may, in theory, push more follicles into the telogen phase prematurely, resulting in increased shedding. This pattern of hair loss is known as telogen effluvium and is typically diffuse rather than patterned. Telogen effluvium usually begins two to three months after the triggering event and is often self-limiting once the underlying cause is addressed.
Additionally, statins reduce circulating cholesterol, which is a precursor to steroid hormones including androgens. Androgens play a recognised role in androgenetic alopecia (pattern hair loss). However, the clinical significance of any statin-induced hormonal changes on hair follicles remains unclear. The theoretical basis for a link exists, but it has not been translated into a predictable or consistently demonstrated clinical effect in controlled studies.
How Common Is Hair Loss With Pravastatin?
Alopecia is classified as rare with pravastatin, potentially affecting up to 1 in 1,000 patients, based on the UK SmPC; incidence is difficult to establish reliably due to under-reporting and overlap with common population hair loss.
Assessing the true frequency of hair loss with pravastatin is challenging. Spontaneous adverse event reporting systems, such as the MHRA Yellow Card scheme, capture reports submitted voluntarily by patients and healthcare professionals. These are subject to under-reporting and cannot reliably establish incidence rates or confirm causality.
According to the current UK SmPC for pravastatin sodium, alopecia is classified as a rare adverse effect, meaning it may affect up to 1 in 1,000 patients. Patients and clinicians should refer to the SmPC or the BNF for the full and current list of adverse reactions and their frequencies, as these represent the authoritative UK source. Alopecia has also been reported across the statin class more broadly, including with atorvastatin, simvastatin, and rosuvastatin, though frequency classifications may differ between products.
For context, adverse effects reported more commonly with pravastatin (as listed in the SmPC) include gastrointestinal disturbances such as nausea, diarrhoea, and constipation, as well as headache. Muscle-related symptoms (such as myalgia) and changes in liver enzyme levels have also been reported; patients should consult the SmPC or BNF for the precise frequency categories applicable to pravastatin specifically, as these differ from class-wide figures.
Hair loss is also a common condition in the general population, particularly in middle-aged and older adults — the same demographic most likely to be prescribed statins. This overlap makes it difficult to attribute hair loss definitively to pravastatin without careful clinical assessment. A GP can help determine whether the timing of hair loss correlates with starting pravastatin or a dose change, which is an important clue when evaluating a potential drug-related cause.
Other Medications and Conditions That Can Cause Hair Loss
Thyroid disorders, iron deficiency anaemia, androgenetic alopecia, and medicines such as anticoagulants and beta-blockers are all common causes of hair loss that must be excluded before attributing it to pravastatin.
Before attributing hair loss to pravastatin, it is essential to consider the many other potential causes, both medical and medication-related. Hair loss is a non-specific symptom with a broad differential diagnosis, and identifying the correct cause is important for appropriate management.
Medical conditions commonly associated with hair loss include:
-
Thyroid disorders — both hypothyroidism and hyperthyroidism can cause diffuse hair thinning
-
Iron deficiency anaemia — a very common and treatable cause, particularly in women
-
Alopecia areata — an autoimmune condition causing patchy hair loss
-
Androgenetic alopecia — the most common form of hair loss, influenced by genetics and hormones
-
Telogen effluvium — triggered by physical or emotional stress, illness, surgery, or significant weight loss
-
Scalp infections — such as tinea capitis (ringworm of the scalp), which is particularly important to consider in children with patchy hair loss and requires prompt assessment
-
Scarring (cicatricial) alopecias — a group of inflammatory conditions that can permanently damage hair follicles if not treated promptly
Medicines known to cause hair loss include:
-
Anticoagulants (e.g., warfarin, heparin)
-
Antithyroid drugs (e.g., carbimazole)
-
Retinoids (e.g., acitretin)
-
Certain antidepressants and mood stabilisers
-
Chemotherapy agents
-
Beta-blockers
-
Oral contraceptives (particularly on cessation)
Many patients taking pravastatin are also prescribed multiple medicines for cardiovascular risk factors, such as antihypertensives or anticoagulants, which themselves carry a risk of alopecia. A thorough medication review by a GP or pharmacist is therefore an important first step.
In line with NICE Clinical Knowledge Summaries (CKS) guidance on hair loss, blood tests to help exclude common causes typically include a full blood count (FBC), ferritin, and thyroid function tests (TFTs). Depending on the clinical history and examination findings, a GP may also check vitamin B12, vitamin D, zinc, or C-reactive protein (CRP). These investigations should be guided by the individual clinical picture rather than performed routinely in every case.
What to Do If You Notice Hair Loss While Taking Pravastatin
Do not stop pravastatin without speaking to your GP first; arrange a review so they can assess the timeline, arrange blood tests, review your full medication list, and consider referral or switching to an alternative statin if needed.
If you notice increased hair shedding or thinning while taking pravastatin, the most important first step is not to stop your medication without speaking to your GP. Pravastatin is prescribed for significant cardiovascular risk reduction, and stopping it abruptly could increase your risk of serious events such as heart attack or stroke. The potential benefit of the medication must always be weighed carefully against any side effects.
Arrange an appointment with your GP to discuss your concerns. They will likely:
-
Review the timeline — establishing whether hair loss began after starting pravastatin or following a dose change is clinically relevant
-
Arrange blood tests — including TFTs, FBC, and ferritin, with additional tests (e.g., vitamin B12, vitamin D, zinc, CRP) guided by your history and examination
-
Review your full medication list — to identify any other medicines that may be contributing
-
Consider referral to a dermatologist if the cause remains unclear, if hair loss is significant and distressing, or if any red-flag features are present
Seek prompt medical attention if you notice any of the following:
-
A painful, inflamed, or scarring scalp
-
Rapid or extensive hair loss
-
Patchy hair loss in a child (which may suggest tinea capitis)
-
Hair loss accompanied by systemic symptoms such as fatigue, weight change, or skin changes
These features may indicate a condition requiring timely assessment and should not be attributed to a medicine without proper evaluation.
If pravastatin is suspected as the cause after other conditions have been excluded, your GP may consider switching you to an alternative statin. Different statins have different pharmacokinetic profiles — for example, pravastatin is hydrophilic (water-soluble), whereas atorvastatin and simvastatin are lipophilic (fat-soluble). Some clinicians have suggested that lipophilicity may influence the likelihood of certain side effects; however, evidence specifically linking this property to differences in hair loss risk is limited and uncertain. If statin intolerance is confirmed, your GP may also discuss non-statin lipid-lowering options (such as ezetimibe) in line with NICE NG238 guidance.
You can report suspected side effects directly to the MHRA via the Yellow Card scheme (yellowcard.mhra.gov.uk). Reporting your experience contributes to the ongoing monitoring of medicine safety and helps regulators and clinicians better understand the real-world effects of statins for all patients.
Frequently Asked Questions
Can pravastatin cause hair loss, and how likely is it?
Pravastatin can cause hair loss, but it is classified as a rare adverse effect, potentially affecting up to 1 in 1,000 patients according to its UK Summary of Product Characteristics. Large clinical trials have not consistently confirmed a direct causal link, and most reports come from post-marketing surveillance rather than controlled studies.
Should I stop taking pravastatin if I think it is causing my hair to fall out?
No — do not stop pravastatin without speaking to your GP first, as it is prescribed to significantly reduce your risk of heart attack and stroke. Your GP can investigate other possible causes, review your medications, and consider switching you to an alternative statin if pravastatin is suspected after other causes have been excluded.
Is hair loss more common with some statins than others?
Alopecia has been reported across the statin class, including with atorvastatin, simvastatin, and rosuvastatin, though frequency classifications may differ between products. Some clinicians have suggested that a statin's lipophilicity (fat-solubility) may influence certain side effects, but evidence specifically linking this property to differences in hair loss risk is limited and uncertain.
What blood tests should I have if I am losing hair while on pravastatin?
Your GP will typically arrange a full blood count (FBC), ferritin, and thyroid function tests (TFTs) to help exclude common causes such as iron deficiency anaemia and thyroid disorders. Depending on your clinical history and examination, they may also check vitamin B12, vitamin D, zinc, or C-reactive protein (CRP).
Can other medicines I take alongside pravastatin cause hair loss?
Yes — many medicines commonly prescribed alongside pravastatin for cardiovascular risk factors can cause hair loss, including anticoagulants such as warfarin, beta-blockers, and antithyroid drugs. A thorough medication review by your GP or pharmacist is an important first step before attributing hair loss to pravastatin specifically.
How do I report hair loss as a side effect of pravastatin in the UK?
You can report suspected side effects, including hair loss, directly to the MHRA via the Yellow Card scheme at yellowcard.mhra.gov.uk. Reporting your experience helps regulators and clinicians better understand the real-world effects of statins and contributes to ongoing medicine safety monitoring.
The health-related content published on this site is based on credible scientific sources and is periodically reviewed to ensure accuracy and relevance. Although we aim to reflect the most current medical knowledge, the material is meant for general education and awareness only.
The information on this site is not a substitute for professional medical advice. For any health concerns, please speak with a qualified medical professional. By using this information, you acknowledge responsibility for any decisions made and understand we are not liable for any consequences that may result.
Any third-party brands or services referenced on this site are included for informational purposes only; we are entirely independent and have no affiliation, partnership, or collaboration with any companies mentioned.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Heading 6
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.
Block quote
Ordered list
- Item 1
- Item 2
- Item 3
Unordered list
- Item A
- Item B
- Item C
Bold text
Emphasis
Superscript
Subscript
